The Future of Robotics in Healthcare

Valued at US$4.6 billion in 2020, the global surgical robotics market is rapidly expanding at a CAGR of 17.4% and it's estimated to reach US$13.8 billion by 2028. The Asia Pacific surgical robotics market, in particular worth around US$918 million in 2020 is forecast to grow significantly. This is especially notable in an area where most of the population currently does not have access to proper healthcare.

While surgical robotics have been in use for years, endovascular robotics is a relatively new entrant in minimally invasive interventions and helps to clear blocked coronary and peripheral arteries and has clearance in select countries for coiling in aneurysms. Robotic-assisted interventions offer greater procedural precision and standardization, and protection from the radiation hazards in a cathlab. There is also the potential of performing robotic-assisted interventions remotely in the future. When combined with advanced image guidance and supported by high-speed communications technology, remote robotics could truly democratize healthcare and expand access to healthcare to more patients where they need it, when they need it.

Join Dr. Paul Ong, Senior Interventional Cardiologist at Mount Elizabeth Novena Hospital, Dr. Adam Chee, Chief of Smart Health Leadership Centre at National University of Singapore and Rajat Nag, Head of Asia Pacific at Corindus, a Siemens Healthineers company, for a webinar on 18 August 2021, as they take a deeper look at the current state of the endovascular robotics market in Asia Pacific, examine the technology trends underpinning robotic systems, and explore opportunities to provide better healthcare for all.